SCHEMBL23309702

SCHEMBL23309702

Cc1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ NPC1 O15118 6/20 0.48
▸ RAB9A P51151 6/20 0.48
▸ TP53 P04637 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ POLB P06746 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.45
▸ PRNP P04156 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KCNQ3 O43525 2/20 0.44
▸ KCNQ2 O43526 2/20 0.44
▸ KCNE1 P15382 2/20 0.44
▸ KCNQ1 P51787 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ KCNQ5 Q9NR82 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309483 0.90 CYP1A2 (0.52) ALDH1A1HSD17B10NPC1RAB9ATP53
SCHEMBL23309533 0.89 ALDH1A1 (0.43) ALDH1A1HSD17B10NPC1RAB9ALMNA
SCHEMBL23309703 0.87 RAB9A (0.51) ALDH1A1NPC1RAB9ATP53LMNA
SCHEMBL23309492 0.87 RAB9A (0.45) ALDH1A1HSD17B10NPC1RAB9ALMNA
SCHEMBL23309539 0.87 NPC1 (0.52) ALDH1A1HSD17B10NPC1RAB9ATP53
SCHEMBL23309566 0.87 ALDH1A1 (0.41) ALDH1A1HSD17B10NPC1RAB9APOLB
SCHEMBL23309730 0.85 KMT2A (0.47) ALDH1A1NPC1RAB9ALMNAMAPT
SCHEMBL23309715 0.85 SORT1 (0.46) NPC1RAB9ALMNAMAPTKMT2A
SCHEMBL23309621 0.85 RAB9A (0.50) ALDH1A1HSD17B10NPC1RAB9ATP53
SCHEMBL23309531 0.84 MAOB (0.49) NPC1RAB9AMAPTKMT2AKCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL ALDH1A1 2033/4885HSD17B10 1857/4885NPC1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback